Monograph Details
|
|
Dermatological Disorders
> Skin infections (topicals)
|
|
MENTAX |
| Manufacturer |
|
Bertek Pharmaceuticals, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Benzylamine antifungal. |
| Generic Name |
|
Butenafine HCl 1%; crm. |
| Indications |
|
Tinea versicolor, t. corporis, t. cruris, and interdigital t. pedis. |
| Children |
|
Not recommended. |
| Adults |
|
Apply to affected and immediately surrounding area. T. versicolor, corporis, cruris: Apply once daily for 2 wks. T. pedis: Apply twice daily for 1 wk, or once daily for 4 wks. Reevaluate if no improvement after therapy. |
| Precautions |
|
Avoid eyes, nose, mouth, mucous membranes. Do not occlude. Discontinue if irritation develops and confirm diagnosis. Sensitivity to allylamines. Pregnancy (Cat.B). Nursing mothers. |
| Adverse Reactions |
|
Burning/stinging, worsening of condition, other local irritation. |
| How Supplied |
|
Crm—15g, 30g |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
